Haiti vs Venezuela, Bolivarian Republic of: Immunization, Hib3
Haiti
60.0%
in 2024
Venezuela, Bolivarian Republic of
62.0%
in 2024
Haiti rank
182nd
Venezuela, Bolivarian Republic of rank
180th
Immunization, Hib3 over time
- Haiti
- Venezuela, Bolivarian Republic of
How they compare
Venezuela, Bolivarian Republic of currently reports 62.0% against 60.0% in Haiti, a difference of 2.0%.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was Venezuela, Bolivarian Republic of ahead.
Haiti ranks 182nd and Venezuela, Bolivarian Republic of ranks 180th of 191 countries.
Venezuela, Bolivarian Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Haiti | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 60.1% | 74.4% | 14.3% | Venezuela, Bolivarian Republic of |
| 2020s | 53.6% | 53.8% | 0.2% | Venezuela, Bolivarian Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Haiti or Venezuela, Bolivarian Republic of?
- Venezuela, Bolivarian Republic of, at 62.0% against 60.0% in Haiti as of 2024.
- What is the difference in immunization, hib3 between Haiti and Venezuela, Bolivarian Republic of?
- 2.0%, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Haiti and Venezuela, Bolivarian Republic of?
- 12 years are reported by both, from 2013 to 2024.
- How do Haiti and Venezuela, Bolivarian Republic of rank globally for immunization, hib3?
- Haiti ranks 182nd and Venezuela, Bolivarian Republic of ranks 180th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.